Northwest Georgia Oncology Centers Marietta

Marietta, Georgia 30060-1152

0 studies enrolling now · 5 studies all time

What they study most

ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Chronic Lymphocytic Leukemia, Lung Non-Squamous Non-Small Cell Carcinoma, Marginal Zone Lymphoma, Relapsed/Refractory Follicular Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Lung Cancer AJCC v8

Studies at this site

• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) — Running, not enrolling
• A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia — Running, not enrolling
• Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) — Running, not enrolling
• Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) — Running, not enrolling